The company expired its plan on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.83 CNY | -1.70% | -4.56% | +5.02% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.02% | 744M | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 4, 2021, has expired with 11,355,900 shares, representing 2.09% for CNY 174.83 million.